Group 1 - Beijing Tongrentang Group issued a statement on December 20 regarding issues related to "Antarctic krill oil," which has drawn significant attention from the Shanghai Consumer Protection Committee [1] - The company acknowledged the problem and expressed regret to consumers and society, committing to legal compensation for consumers and launching a "zero tolerance" brand management initiative, reflecting its commitment to consumer rights and rectification [1] - The corrective measures introduced by Beijing Tongrentang respond to the demands raised by the Shanghai Consumer Protection Committee during discussions with relevant operators, although the effectiveness of these measures will ultimately be judged by consumer experiences [1] Group 2 - The Shanghai Consumer Protection Committee is conducting social supervision and consumer reminders regarding the Antarctic krill oil product issues, fulfilling its role in protecting consumer rights and aiming to purify the health functional food market while maintaining the reputation of time-honored brands [1] - Beijing Tongrentang, with a history of 356 years, holds a significant position in the minds of consumers, which necessitates careful preservation [1] - The company is expected to use this incident as an opportunity to implement long-term brand maintenance and trust-building mechanisms, contributing to a healthy and orderly consumption environment [1]

Core Viewpoint - Beijing Tongrentang Group has acknowledged issues related to "Antarctic Krill Oil" and is taking corrective measures in response to consumer concerns raised by the Shanghai Consumer Protection Committee [1] Group 1: Company Response - The company has shown a proactive attitude in addressing the problems identified with its Antarctic Krill Oil products [1] - Corrective measures introduced by the company are a direct response to the demands of consumers represented by the Shanghai Consumer Protection Committee during discussions with relevant operators [1] - The effectiveness of these corrective actions will ultimately be judged by the actual experiences of consumers [1] Group 2: Regulatory Oversight - The Shanghai Consumer Protection Committee is conducting social supervision and consumer reminders regarding the Antarctic Krill Oil product issues [1] - This oversight is part of the committee's responsibility to protect consumer rights and aims to purify the market for health functional foods [1] - The initiative also seeks to maintain the reputation of time-honored Chinese brands [1]

Core Viewpoint - Beijing Tongrentang Group has issued an apology regarding the recent controversy surrounding "Antarctic Krill Oil," expressing deep concern for consumer rights and initiating a thorough investigation into the matter [1][3]. Group 1: Company Response - The company has launched a zero-tolerance brand management initiative and dispatched a special task force to Sichuan to conduct a comprehensive investigation into the involved products [3]. - The company has ordered the immediate removal of the implicated products from the market and is ensuring compliance with regulatory requirements for consumer compensation [3][4]. - Legal actions will be pursued against Sichuan Health and related e-commerce platforms for trademark infringement and misleading consumers [4]. Group 2: Product Investigation - The Shanghai Consumer Protection Committee has commissioned a study on 15 popular Antarctic krill oil products, focusing on their phospholipid, astaxanthin, EPA, and DHA content [5]. - A product labeled "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to have a phospholipid content of 0%, despite claims of high quality and purity [5]. - The committee plans to interview the manufacturers and distributors of the product to clarify the discrepancies in product claims [5].

Core Viewpoint - Tongrentang Group issued an apology regarding the controversy over "Antarctic krill oil," acknowledging consumer rights damage and committing to a zero-tolerance brand management initiative [1] Group 1: Company Actions - The company has initiated a special task force to conduct a thorough investigation of the implicated products in Sichuan, ensuring a comprehensive inquiry [1] - The company has ordered the immediate removal of the implicated products from the market and will supervise compliance with regulatory requirements for consumer compensation [1] - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading practices [1] Group 2: Product Investigation - The Shanghai Consumer Protection Commission tested 15 popular Antarctic krill oil products, revealing that one product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, indicating potential fraud [4] - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical, with production outsourced to Anhui Habao Pharmaceutical, representing a typical private label model [7] Group 3: Brand Management Issues - The product in question was produced without authorization to prominently feature the "Beijing Tongrentang" name, leading to legal proceedings initiated by the company against the involved entities [7] - Beijing Tongrentang, the sole legal holder of the "Tongrentang" trademark, has faced trust issues due to repeated incidents of private label mismanagement, raising concerns about brand authorization and quality control [7]

同仁堂集团立即开展零容忍品牌严管专项行动，已采取如下措施： 一、派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 二、责令并监督涉事经销主体四川健康立即下架涉事产品，严格按照监管部门要求依法依规对消费者进行赔偿。 三、依法追究四川健康、哈博药业及相关电商平台的商标侵权等责任。对其违法使用"北京同仁堂"字样，误导消费者判断，损害消费者合 法权益的行为追究法律责任。四、对四川健康及其控股股东健康药业等单位在经营、管理、监督环节存在的问题开展问责，严肃追究相关 人员责任。 为进一步保护消费者权益，强化品牌保护责任，同仁堂集团同时开展以下工作： 北京同仁堂发布致歉声明称，针对近日有关"南极磷虾油"的舆论关注，集团对因此给消费者造成的权益损害，向广大消费者和社会各界致 以最诚恳的歉意。 来源：财联社 一、全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核查。 二、全面开展品牌清理行动，坚决清理"擦边"使用"同仁堂"字号、商标使用不规范等行为，严格规范品牌管理体系。 三、全面规范电商平台授权店铺标识，严格使用"同仁堂"双龙图案商标，主动引导消费者准确识别正规购买渠道。 关注" 新华网 ...

12月20日，中国北京同仁堂（集团）有限责任公司发布声明，就此前"南极磷虾油造假风波"致歉，表示 将全面开展品牌清理行动，坚决清理"擦边"使用"同仁堂"字号、商标使用不规范等行为，严格规范品牌 管理体系。 声明全文如下—— 针对近日有关"南极磷虾油"的舆论关注，北京同仁堂集团高度重视、深感痛心，对因此给消费者造成的 权益损害，向广大消费者和社会各界致以最诚恳的歉意！同仁堂集团立即开展零容忍品牌严管专项行 动，已采取如下措施： 一、派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 二、责令并监督涉事经销主体四川健康立即下架涉事产品，严格按照监管部门要求依法依规对消费者进 行赔偿。 一、全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核查。 二、全面开展品牌清理行动，坚决清理"擦边"使用"同仁堂"字号、商标使用不规范等行为，严格规范品 牌管理体系。 三、全面规范电商平台授权店铺标识，严格使用"同仁堂"双龙图案商标，主动引导消费者准确识别正规 购买渠道。 "同仁堂"品牌创立356年来，始终离不开广大消费者的支持和厚爱。我们心怀感恩，诚恳接受社会各界 的监督与批评，愿意与大家一道 ...

Core Viewpoint - The fresh stewed bird's nest market in China is experiencing significant growth, driven by rising health awareness and changing consumer preferences towards preventive health measures, with the market expected to reach 30.7 billion yuan in 2024, a year-on-year increase of 25.8% [1][9]. Overview - Fresh stewed bird's nest is made from bird's nest as the main ingredient, processed without excessive additives, and requires refrigeration due to its short shelf life. It eliminates the complex preparation steps associated with dried bird's nest, catering to the fast-paced urban lifestyle [2][5]. Market Policy - Recent policies in China emphasize food safety, imposing strict requirements on the production, processing, and distribution of fresh stewed bird's nest, which encourages companies to enhance quality control and management [6][7]. Industry Chain - The industry chain includes upstream suppliers of bird's nest and auxiliary materials, midstream production and distribution, and downstream sales channels such as high-end retail, health stores, and e-commerce. The consumer base has expanded to younger demographics, with online sales channels growing from 35.3% in 2018 to 57.8% in 2024 [7][8]. Competitive Landscape - The market is characterized by high concentration, with leading brands like Xiaoxian Stewed and Yanzhiyu dominating the market, holding over 60% market share in 2024. Xiaoxian Stewed focuses on subscription models and efficient cold chain logistics, while Yanzhiyu leverages its extensive offline presence [10][11]. Development Trends - The fresh stewed bird's nest market is expected to see the emergence of functional composite products and personalized services tailored to different consumer needs. Companies will likely increase R&D investments to enhance preservation techniques and collaborate with research institutions to validate product efficacy [11][12].

Core Viewpoint - Tongrentang Group has issued an apology regarding the recent controversy over "Antarctic krill oil," acknowledging the damage caused to consumer rights and committing to a zero-tolerance approach towards brand management [1] Group 1: Company Response - Tongrentang Group has initiated a special action for strict brand management, deploying a task force to Sichuan for a comprehensive investigation of the involved products [1] - The company has ordered the immediate removal of the implicated products from the market and is ensuring compliance with regulatory requirements for consumer compensation [1] - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [1] Group 2: Product Investigation - The Shanghai Consumer Protection Committee conducted tests on 15 popular Antarctic krill oil products, revealing that the "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, indicating potential fraud [3] - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical, with manufacturing outsourced to Habao Pharmaceutical [5] Group 3: Brand Management Issues - Habao Pharmaceutical admitted to not adding the claimed "Antarctic krill oil" during production, and the product packaging was created per the requirements of Sichuan Health Pharmaceutical [5] - The unauthorized use of the "Beijing Tongrentang" name on the product has led to legal proceedings initiated by the company against the involved parties [5] - There are concerns within the industry regarding Tongrentang's brand authorization management and quality control of its subsidiary products, which have contributed to a decline in consumer trust [6]

Core Viewpoint - Beijing Tongrentang Group expresses deep concern and regret over recent public attention regarding "Antarctic Krill Oil," and has initiated a series of measures to protect consumer rights and uphold brand integrity [1][2]. Group 1: Immediate Actions Taken - A special task force has been dispatched to Sichuan to conduct a thorough investigation of the involved products [1]. - The company has ordered the immediate removal of the implicated products from the market and will ensure compliance with regulatory requirements for consumer compensation [1]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading practices that harm consumer rights [1]. Group 2: Brand Protection Initiatives - A comprehensive review of brand usage violations across all levels of the group is being conducted to identify and rectify any illegal or non-compliant practices [2]. - A brand cleanup initiative is underway to eliminate improper use of the "Tongrentang" name and ensure strict adherence to brand management standards [2]. - The company is standardizing the branding of authorized e-commerce stores to ensure the correct use of the "Tongrentang" double-dragon logo, guiding consumers to recognize legitimate purchasing channels [2].

Core Viewpoint - The company is taking immediate and strict actions to protect its brand and consumer rights in response to allegations of false advertising related to a product marketed under its name. Group 1: Brand Protection Measures - The company has initiated a zero-tolerance brand management action, which includes legal accountability for trademark infringement against Sichuan Health, Habo Pharmaceutical, and related e-commerce platforms for misleading consumers [1] - A comprehensive investigation into brand usage violations across all subsidiaries is being conducted to ensure compliance with brand management standards [1] - The company is enforcing strict regulations on e-commerce platform store identifiers to ensure accurate representation of its brand and products [1] Group 2: Response to Allegations - Following allegations of false labeling of a product claiming to contain high levels of phospholipids, the company clarified that the involved entity, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., is not a subsidiary of the company [4] - The company has dispatched a special task force to Sichuan to conduct a thorough investigation into the product in question and has mandated the immediate removal of the product from shelves [5] - The company emphasizes that it focuses on the production and sale of its own pharmaceutical products, with no outsourcing to third parties, ensuring the integrity of its offerings [9]